We are live on ! Find out more
CNSY

Cerenome
CNSY

16 hedge funds and large institutions have $588K invested in Cerenome in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.42% less ownership

Funds ownership: 8.2% → 5.77% (-2.4%)

27% less funds holding

Funds holding: 22 → 16 (-6)

33% less capital invested

Capital invested by funds: $872K → $588K (-$284K)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

86% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 7

Holders
16
Holders Change
-6
Holders Change %
-27.27%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$66.7K
2
Northern Trust
Northern Trust
Illinois
+$9.15K
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$673

Top Sellers

Rank Fund Capital Flow
1
PHP
Parkman Healthcare Partners
Connecticut
-$185K
2
SSA
Schonfeld Strategic Advisors
New York
-$60.4K
3
Millennium Management
Millennium Management
New York
-$24.1K
4
BRWA
B. Riley Wealth Advisors
Florida
-$7.92K
5
UBS Group
UBS Group
Switzerland
-$6.86K

CNSY Hedge Fund Activity: Q1 2023 in Review

16 of the 6,284 institutional investors tracked by Wall St. Rank reported a position in Cerenome (CNSY) for Q1 2023, worth a combined $588K — down 33% from $872K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of CNSY and 1 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was Renaissance Technologies, adding an estimated $66.7K. The largest seller was Parkman Healthcare Partners, exiting entirely with an estimated $185K sold.

  • 16 institutional investors held Cerenome (CNSY) as of Q1 2023, down from 22 in Q4 2022.
  • Funds reported $588K of Cerenome stock for Q1 2023, down 33% quarter-over-quarter.
  • 1 fund opened new Cerenome positions in Q1 2023 and 7 closed out, a net change of -6 holders.
  • The largest Cerenome buyer in Q1 2023 was Renaissance Technologies, an estimated $66.7K added.
  • The largest Cerenome seller in Q1 2023 was Parkman Healthcare Partners, an estimated $185K sold.

Based on aggregated 13F filings for Q1 2023.